查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929599

髋关节手术器械包市场（按产品、手术技术、材料、应用和最终用户划分），全球预测，2026-2032年

Hip Surgery Instrument Set Market by Product Type, Surgical Technique, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年髋关节手术器械套装市值为8.7984亿美元，预计到2026年将成长至9.4475亿美元，年复合成长率为6.81%，到2032年将达到13.9537亿美元。

主要市场统计数据
基准年 2025 8.7984亿美元
预计年份：2026年 9.4475亿美元
预测年份：2032年 13.9537亿美元
复合年增长率 (%) 6.81%

本文从策略角度概述了在现代医疗保健环境中重塑髋关节手术器械采购和使用的临床、营运和供应链驱动因素。

在现代整形外科医疗中，髋关节手术器械是影响临床疗效、手术效率和供应链韧性的关键因素。临床医生日益要求器械能够在有限的手术时间内支援精准的操作，而医疗机构则需要在满足这些临床需求的同时，兼顾成本压力和消毒物流。本报告概述了器械结构、材料选择以及不断变化的手术流程如何共同影响各类医疗机构的采购、培训和长期资产管理决策。

临床创新、材料技术进步和不断变化的医疗服务模式如何推动髋关节手术器材的重新设计和新的筹资策略

髋关节整形外科领域经历了许多变革，彻底改变了器械的设计、应用和管理方式。微创手术和机器人辅助平台的兴起，重新定义了器械的人体工学和模组化要求，推动了对更纤薄、更精准且可与导航系统整合的器械和附件的需求。同时，门诊手术中心和门诊髋关节手术计画的蓬勃发展，也促使製造商生产兼具便携性和全面手术功能的器械套装，使小规模的医疗机构能够在不影响安全性的前提下开展复杂的手术。

评估2025年关税调整以及不断变化的贸易措施对外科设备供应商的采购、成本动态和供应链韧性的影响

2025倡议和贸易措施，特别是影响医疗设备原料和成品的关税调整，为全球供应链带来了更多复杂性。对钛等原料和某些成品征收的关税增加了部分製造商的到岸成本，促使他们调整策略采购策略，并重新聚焦于关键零件的本地生产。由于合约条款需要修订以反映新的关税和物流限制，这些措施对采购计划和供应商谈判产生了连锁反应。

临床和采购的考量细分为产品类型、适应症、最终用户环境、手术方法和材料偏好等，这些因素都会影响器械套装的设计。

对细分市场的深入理解有助于明确器械套装在不同细分市场（包括产品类型、临床应用、终端用户环境、手术技术和材料偏好）中必须满足的不同需求。产品类型包括扩孔器、髋臼杯、锉刀、扩孔钻和原型人工替代物。髋臼杯可再分为骨水泥型、混合型和非骨水泥型，而扩孔钻则细分为髀臼和股骨扩孔钻。每个产品子类别都有其独特的尺寸公差、表面光洁度和器械操作流程，这些都会影响器械套装的配置和灭菌通讯协定。

区域采购模式、监管差异以及先进外科技术的采用如何影响美洲、欧洲、中东、非洲和亚太地区的器械优先事项？

区域趋势对髋关节手术器械包的筹资策略、供应商关係发展以及技术创新应用有显着影响。在美洲，成熟的医院网路和日趋完善的门诊手术中心市场对可重复使用的器械包和一次性辅助器具的需求强劲，促使医疗机构越来越关註生命週期管理合约和服务模式，从而简化资产管理。北美医疗机构也倾向于优先考虑快速获取机器人辅助和导航技术的创新成果，这推动了对早期采用和相容器材的需求。

为什么那些将精密仪器、检验的灭菌支持、材料创新和一体化服务模式相结合的公司能够赢得长期采购合约

髋关节手术器械包生态系统中的领导企业正从单纯的产品供应转型为提供包含器械和临床培训服务协议的整合解决方案。那些拥有经过检验的灭菌流程、可互通的托盘系统和完善的备件供应体系的製造商，正成为重视可预测性和运作的大型医疗机构的首选。随着提供端到端手术生态系统（而非独立工具）的趋势加速发展，器械製造商、手术机器人公司和导航软体供应商之间的策略联盟也日益普遍。

为医疗设备製造商和医疗系统提供切实可行的策略性倡议，透过模组化设计、材料策略和稳健的采购模式，使其仪器产品组合面向未来。

产业领导者应优先考虑以下五个切实可行的步骤，以建立能够应对不断变化的临床、监管和供应链现实的器械包组合。首先，投资于模组化器械包架构，最大限度地减少托盘数量，从而降低灭菌量和储存需求，同时能够快速重新配置以适应大型手术和翻修手术。其次，将钛和先进不銹钢合金的选择性使用纳入材料策略，以平衡外科医生对手术操作性能的要求与高强度使用环境所需的耐用性。

结合临床访谈、供应链分析、材料审查和专家检验的严谨混合方法，可为您的器材策略提供切实可行的见解。

本研究的结论是基于混合研究方法，整合了定性访谈、有针对性的二手研究以及临床、采购和供应链来源之间的三角验证。主要研究包括对骨科医生、消毒供应中心经理、医院和门诊中心采购主管以及产品开发主管的深入访谈；这些访谈提供了关于器械人体工学、托盘配置偏好和再处理挑战的实用见解。

整合关键的临床、营运和供应链问题，以确定哪些仪器策略能够提供持续的临床效能和营运韧性。

髋关节手术器械市场正处于转折点，临床创新、材料选择和供应链策略的交汇点将决定手术效率和采购结果。微创手术和机器人辅助手术的发展趋势要求器械组合必须互通性、符合人体工学，并与现代工作流程相容。同时，关税和区域采购差异带来的供应链压力要求检验的筹资策略和本地化的服务能力，以维持供应的连续性和手术效率。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 按产品类型分類的髋关节手术器械套装市场

  • 胸针
  • 杯子
    • 水泥固定
    • 杂交种
    • 非水泥型
  • 锉刀
  • 扩孔器
    • 髀臼
    • 股骨
  • 用于测试的人工关节

9. 依手术技术分類的髋关节手术器械套装市场

  • 微创手术
    • 前路入路
    • 侧入路
    • 后路入路
  • 机器人辅助
  • 传统方法

第十章 按材料分類的髋关节手术器械套装市场

  • 免洗塑胶
  • 防锈的
  • 钛

第十一章 按应用分類的髋关节手术器械套装市场

  • 初次髋关节置换术
  • 髋重新置换置换术
    • 部分置换术
    • 全置换术

第十二章 依最终用户分類的髋关节手术器械套装市场

  • 门诊手术中心
  • 医院
  • 专业整形外科诊所

第十三章 各地区髋关节手术器械套装市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 髋关节手术器械套装市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国髋关节手术器械套装市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国髋关节手术器械套装市场

第十七章 中国髋关节手术器材套装市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acumed LLC
  • Aesculap, Inc.
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Conmed Corporation
  • DJO, LLC
  • Exactech, Inc.
  • HipInnovation LLC
  • Integra LifeSciences Corporation
  • Medacta International SA
  • Medtronic plc
  • MicroPort Orthopedics, Inc.
  • MicroPort Scientific Corporation
  • Orthofix Medical Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Trauson Holdings Co., Ltd.
  • Wright Medical Group NV
  • Zimmer Biomet Holdings, Inc.
  • Zimmer, Inc.
Product Code: MRR-0A3806951842

The Hip Surgery Instrument Set Market was valued at USD 879.84 million in 2025 and is projected to grow to USD 944.75 million in 2026, with a CAGR of 6.81%, reaching USD 1,395.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 879.84 million
Estimated Year [2026] USD 944.75 million
Forecast Year [2032] USD 1,395.37 million
CAGR (%) 6.81%

A strategic overview framing clinical, operational, and supply chain drivers that are reshaping procurement and use of hip surgery instrument sets in modern care settings

Hip surgery instrument sets occupy a critical nexus between clinical outcomes, procedural efficiency, and supply chain resilience within contemporary orthopedic care. Clinicians increasingly demand instruments that support precision techniques while operating within constrained procedural windows, and institutions balance those clinical requirements against cost pressures and sterilization logistics. This report synthesizes how instrument architecture, material choices, and evolving surgical workflows collectively influence procurement, training, and long-term asset management decisions across provider types.

Stakeholders that influence instrument set selection span surgeons, perioperative nurses, sterile processing teams, hospital procurement, and ambulatory surgery administrators. Each constituency brings unique performance criteria: surgeons prioritize ergonomics and tactile feedback, sterile processing teams emphasize reprocessing durability and tracking, and procurement views lifecycle cost and supplier reliability as primary determinants. Understanding these intersecting priorities clarifies why a one-size-fits-all approach to instrument sets no longer suffices and why modular, interoperable solutions are gaining traction.

The narrative that follows explores how shifts in surgical technique, materials innovation, regulatory scrutiny, and trade dynamics reshape the landscape for hip surgery instrument sets. By anchoring the analysis in practical operational realities and recent technological adoption patterns, readers will gain a structured view of the risks and opportunities that should inform near-term investment and procurement decisions.

How clinical innovations, material advances, and shifting care delivery patterns are compelling redesign and new procurement strategies for hip surgery instrument sets

The orthopedics landscape for hip procedures has undergone several transformative shifts that are changing how instrument sets are designed, deployed, and managed. Minimally invasive approaches and the rise of robot-assisted platforms have redefined instrument ergonomics and modularity requirements, driving demand for slimmer, more precise instruments and attachments that integrate with navigation systems. Concurrently, the growth of ambulatory surgery centers and outpatient hip programs has pressured manufacturers to produce instrument sets that balance portability with comprehensive procedural functionality, allowing smaller sites to perform complex cases without compromising safety.

Material innovation continues to be a decisive factor. Advances in stainless steel metallurgy and the broader adoption of titanium for specific components have enhanced durability and reduced instrument weight, while the increased use of disposable plastics for selected single-use items mitigates reprocessing risk and turnaround constraints. Regulatory emphasis on traceability and sterilization validation has pushed suppliers to embed unique device identification, sterilization cycle compatibility, and validated maintenance instructions into product documentation and service offerings.

This period also features a pronounced focus on sustainability and total cost of ownership within procurement cycles. Healthcare systems are increasingly evaluating the environmental and operational footprint of reusable versus disposable components, balancing infection control priorities with lifecycle implications. Taken together, these shifts are prompting more strategic collaboration between clinicians, hospital administrators, and suppliers to co-design instrument portfolios that meet clinical objectives while optimizing logistical and financial performance.

Assessment of 2025 tariff adjustments and how evolving trade measures are altering sourcing, cost dynamics, and supply chain resilience for surgical instrument suppliers

Policy and trade actions in 2025, including tariff adjustments affecting medical device inputs and finished instruments, have introduced an additional layer of complexity across global supply chains. Tariffs on raw materials such as titanium and on certain finished goods have increased landed costs for some manufacturers, prompting strategic sourcing adjustments and renewed emphasis on localized manufacturing for critical components. These measures have had cascading effects across procurement timelines and supplier negotiations, as contract terms are revisited to reflect new duties and logistics constraints.

Hospitals and ambulatory centers responded by intensifying supplier diversification efforts and by accelerating conversations about total lifecycle costs. Purchasing teams are increasingly seeking flexible pricing structures, multi-year agreements with tariff pass-through clauses, and inventory strategies that can buffer short-term tariff volatility. In parallel, some manufacturers have sought to redesign instrument kits to reduce reliance on tariff-affected components, substitute materials where clinically appropriate, and qualify alternative vendors in lower-tariff jurisdictions to stabilize supply.

The tariff-driven recalibration has also influenced decisions around disposable versus reusable components. Where duties make imported reusable components more costly, single-use alternatives-sourced domestically or from preferential trade partners-have become more attractive despite differing environmental and waste-management considerations. Ultimately, organizations that proactively integrated tariff scenarios into procurement planning and that maintained flexible supplier networks were better positioned to mitigate disruption and preserve procedural throughput.

Segmented clinical and procurement considerations across product types, procedural indications, end-user settings, surgical access approaches, and material preferences influencing instrument set design

A granular understanding of segmentation clarifies the divergent needs that instrument sets must satisfy across product categories, clinical applications, end-user environments, surgical techniques, and material preferences. Product-type differentiation encompasses broaches, cups, rasps, reamers, and trial prostheses, with cups further delineated into cemented, hybrid, and uncemented variants and reamers subdivided into acetabular and femoral designs. Each product subcategory imposes distinct dimensional tolerances, surface finishes, and instrumentation workflows that influence set composition and sterilization protocols.

On the application axis, primary hip replacement and revision hip replacement create distinct procedural demands: revision work, whether partial or total, often requires expanded instrument inventories and adaptable trialing components to address varied bone loss patterns and implant compatibility challenges. End-user environments-ambulatory surgery centers, hospitals, and specialized orthopedic clinics-differ in storage capacity, sterilization infrastructure, and procedural volume, which in turn dictate preferences for modular trays, compact instrument kits, or expanded case carts.

Surgical technique further shapes instrument design priorities. Minimally invasive approaches, including anterior, lateral, and posterior access routes, increase demand for low-profile instruments and optimized retraction systems, while robot-assisted workflows necessitate instrument interfaces compatible with guidance platforms and navigation. Traditional access continues to require robust, reusable instruments with proven longevity. Material choice completes the segmentation picture: disposable plastics, stainless steel, and titanium each present trade-offs in weight, durability, reprocessing complexity, and cost that procurement and clinical teams must reconcile when specifying instrument sets.

How regional procurement models, regulatory variability, and adoption of advanced surgical techniques are shaping instrument set priorities across Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence procurement strategies, supplier relationships, and innovation adoption for hip surgery instrument sets. In the Americas, established hospital networks and a mature ambulatory surgery center market create strong demand for both reusable instrument suites and single-use adjuncts, with institutions showing heightened interest in lifecycle management agreements and service-based models that simplify asset maintenance. North American providers also tend to prioritize rapid access to innovations in robotic assistance and navigation, driving early adoption and associated demand for compatible instruments.

Europe, the Middle East, and Africa present a heterogeneous mix of regulatory regimes and procurement practices where some markets emphasize centralized purchasing and strict sterilization standards, while others prioritize cost containment and local production. In this broad region, partnerships between international suppliers and regional distributors are crucial for navigating complex reimbursement landscapes and for ensuring consistent training and support for advanced surgical techniques.

Asia-Pacific exhibits substantial variation across high-volume urban centers and emerging regional markets. Providers in advanced centers are rapidly integrating robot-assisted systems and minimally invasive approaches, increasing demand for specialized instrument interfaces and precision components, while other markets emphasize cost-effective, durable instruments that can withstand high utilization rates and intermittent sterilization capacity. Across all regions, localized manufacturing, robust distribution networks, and tailored training programs remain critical enablers of successful instrument set deployment.

Why companies that combine precision instrumentation, validated sterilization support, materials innovation, and integrated service models are winning long-term procurement commitments

Leading companies in the hip surgery instrument set ecosystem are evolving beyond commodity supply to offer integrated solutions that combine instrumentation, clinical training, and service contracts. Manufacturers that differentiate through validated sterilization instructions, interoperable tray systems, and robust spare-part programs gain preference among large health systems that value predictability and uptime. Strategic partnerships between instrument makers, surgical robotics firms, and navigation software providers are increasingly common as companies seek to offer end-to-end procedural ecosystems rather than standalone tools.

Supply-side consolidation and vertical integration are also visible, with some firms investing in localized manufacturing and expanded service footprints to protect against trade and logistics disruptions. Companies that invest in materials science-optimizing stainless steel alloys and selectively applying titanium to reduce weight while maintaining strength-position their portfolios to meet surgeon demands for tactile performance and longevity. Meanwhile, manufacturers that embrace sterilization science and provide validated reprocessing cycles, training for sterile processing teams, and digital tracking solutions enhance clinical confidence and minimize lifecycle risk.

Distribution partners and service providers that offer inventory management, tray reconfiguration services, and modular kit design support further differentiate themselves in competitive procurement cycles. Firms that align product roadmaps with surgeon feedback loops and deliver timely clinical education are more likely to secure long-term framework agreements with hospitals and ambulatory centers.

Actionable strategic initiatives for device makers and health systems to future-proof instrument portfolios through modular design, materials strategy, and resilient sourcing models

Industry leaders should prioritize five pragmatic initiatives to align instrument set portfolios with evolving clinical, regulatory, and supply chain realities. First, invest in modular kit architectures that allow rapid reconfiguration for primary and revision procedures while minimizing tray counts to reduce sterilization throughput and storage demands. Second, expand materials strategy to include selective use of titanium and advanced stainless alloys to balance surgeon preferences for performance with the durability required for high-volume environments.

Third, develop flexible sourcing and manufacturing footprints that mitigate tariff and logistics volatility by qualifying alternate suppliers and establishing regional production capabilities for critical components. Fourth, deepen service offerings by providing validated reprocessing instructions, digital tracking for instrument lifecycle management, and training programs tailored to both surgical and sterile processing teams, which together reduce risk and improve OR efficiency. Finally, collaborate with clinical partners and robotics/navigation vendors to ensure instrument interfaces support emerging surgical workflows, investing in co-development where appropriate to accelerate adoption.

Implementing these actions demands cross-functional alignment between R&D, commercial, and operations teams, as well as structured feedback loops with frontline clinicians. Organizations that take a proactive, systems-oriented approach will be better positioned to capture procedural preferences, control lifecycle costs, and sustain competitive differentiation in an environment defined by rapid technological and policy shifts.

A rigorous mixed-methods approach combining clinical interviews, supply chain analysis, materials review, and expert validation to underpin actionable insights for instrument strategy

This study's conclusions derive from a mixed-methods research approach that integrated primary qualitative interviews, targeted secondary research, and triangulation across clinical, procurement, and supply chain sources. Primary research included in-depth interviews with orthopedic surgeons, sterile processing managers, procurement leaders at hospitals and ambulatory centers, and product development executives; these conversations informed practical insights on instrument ergonomics, tray configuration preferences, and reprocessing challenges.

Secondary analysis encompassed regulatory guidance, clinical literature on surgical approaches and outcomes, materials science publications related to instrument metallurgy, and publicly available manufacturer technical documentation. Supply chain analysis examined trade policy changes, tariff schedules, and logistics constraints as they affect component sourcing and landed costs, while case studies of procurement decisions provided real-world examples of mitigation strategies used by providers.

Throughout the research process, findings were validated via cross-stakeholder workshops and expert review sessions to ensure that conclusions reflect operational realities. Data integrity measures included source triangulation, methodological transparency, and iterative review with clinical experts to align technical descriptions with practical surgical workflows. This layered methodology supports robust, actionable insights that inform procurement, product development, and strategic planning.

Synthesis of clinical, operational, and supply chain imperatives that will determine which instrument strategies deliver sustained clinical performance and operational resilience

The hip surgery instrument set landscape is at an inflection point where clinical innovation, material selection, and supply chain strategy intersect to determine procedural efficiency and procurement outcomes. Surgical trends toward minimally invasive and robot-assisted procedures demand instrument portfolios that are interoperable, ergonomically optimized, and validated for modern workflows. At the same time, tariff-induced supply chain pressures and regional procurement differences require flexible sourcing strategies and localized service capabilities to maintain continuity of supply and procedural throughput.

Successful stakeholders will be those who take a systems-oriented view: aligning product design with sterilization workflows, embedding validated reprocessing instructions, and offering modular kit solutions that reduce OR complexity. Companies that invest in materials innovation and build resilient, regionally diversified manufacturing footprints will be better insulated from trade and logistics shocks. For providers, prioritizing partnerships that deliver training, after-sales support, and digital lifecycle management will yield measurable gains in efficiency and clinical confidence.

In sum, intentional collaboration among clinicians, procurement, and suppliers-backed by robust data and flexible commercial models-will be essential to unlocking sustained improvements in hip surgery outcomes and operational performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Surgery Instrument Set Market, by Product Type

  • 8.1. Broaches
  • 8.2. Cups
    • 8.2.1. Cemented
    • 8.2.2. Hybrid
    • 8.2.3. Uncemented
  • 8.3. Rasps
  • 8.4. Reamers
    • 8.4.1. Acetabular
    • 8.4.2. Femoral
  • 8.5. Trial Prosthesis

9. Hip Surgery Instrument Set Market, by Surgical Technique

  • 9.1. Minimally Invasive
    • 9.1.1. Anterior
    • 9.1.2. Lateral
    • 9.1.3. Posterior
  • 9.2. Robot Assisted
  • 9.3. Traditional Access

10. Hip Surgery Instrument Set Market, by Material

  • 10.1. Disposable Plastics
  • 10.2. Stainless Steel
  • 10.3. Titanium

11. Hip Surgery Instrument Set Market, by Application

  • 11.1. Primary Hip Replacement
  • 11.2. Revision Hip Replacement
    • 11.2.1. Partial Revision
    • 11.2.2. Total Revision

12. Hip Surgery Instrument Set Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Hospitals
  • 12.3. Specialized Orthopedic Clinics

13. Hip Surgery Instrument Set Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Surgery Instrument Set Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Surgery Instrument Set Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hip Surgery Instrument Set Market

17. China Hip Surgery Instrument Set Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Acumed LLC
  • 18.6. Aesculap, Inc.
  • 18.7. Arthrex, Inc.
  • 18.8. B. Braun Melsungen AG
  • 18.9. Conmed Corporation
  • 18.10. DJO, LLC
  • 18.11. Exactech, Inc.
  • 18.12. HipInnovation LLC
  • 18.13. Integra LifeSciences Corporation
  • 18.14. Medacta International SA
  • 18.15. Medtronic plc
  • 18.16. MicroPort Orthopedics, Inc.
  • 18.17. MicroPort Scientific Corporation
  • 18.18. Orthofix Medical Inc.
  • 18.19. Smith & Nephew plc
  • 18.20. Stryker Corporation
  • 18.21. Trauson Holdings Co., Ltd.
  • 18.22. Wright Medical Group N.V.
  • 18.23. Zimmer Biomet Holdings, Inc.
  • 18.24. Zimmer, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIP SURGERY INSTRUMENT SET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY BROACHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY UNCEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY RASPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ACETABULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY FEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRIAL PROSTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ANTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY LATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY POSTERIOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY ROBOT ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TRADITIONAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY DISPOSABLE PLASTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRIMARY HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PARTIAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY TOTAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 185. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 188. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. GCC HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 220. G7 HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 230. NATO HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL HIP SURGERY INSTRUMENT SET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY CUPS, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REAMERS, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY REVISION HIP REPLACEMENT, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA HIP SURGERY INSTRUMENT SET MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)